Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
HSL CRISPR Activation Plasmid (h): sc-401341-ACT
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- HSL CRISPR Activation Plasmid (h) is a synergistic activation mediator (SAM) transcription activation system designed to specifically upregulate gene expression
- HSL CRISPR Activation Plasmid (h) consists of three plasmids at a 1:1:1 mass ratio: a plasmid encoding the deactivated Cas9 (dCas9) nuclease (D10A and N863A) fused to the transactivation domain VP64, and a blasticidin resistance gene; a plasmid encoding the MS2-p65-HSF1 fusion protein, and a hygromycin resistance gene; a plasmid encoding a target-specific 20 nt guide RNA fused to two MS2 RNA aptamers, and a puromycin resistance gene
- The resulting SAM complex binds to a site-specific region approximately 200-250 nt upstream of the transcriptional start site and provides robust recruitment of transcription factors for highly efficient gene activation
- gRNAs encoded by HSL CRISPR Activation Plasmid (h) and HSL CRISPR Activation Plasmid (h2) target distinct regulatory regions upstream of the LIPE transcriptional start site. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: HSL Antibody (G-7): sc-74489
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
HSL CRISPR Activation Plasmid (h) | sc-401341-ACT | 20 µg | $397.00 |
Human LIPE encodes hormone-sensitive lipase (HSL), a key neutral lipase that hydrolyzes diacylglycerol and other lipid esters to regulate intracellular lipid mobilization. HSL activity integrates catecholamine and insulin signaling via cAMP/PKA-dependent phosphorylation and coordinated lipid droplet dynamics, supporting energy homeostasis in adipocytes and steroidogenic tissues. Altered LIPE/HSL regulation has been associated with disrupted lipolysis, ectopic lipid accumulation, and metabolic phenotypes linked to insulin resistance and dyslipidemia, making it a relevant target for studying lipid signaling and metabolic adaptation. In addition, LIPE-dependent lipid flux can influence inflammatory pathways and cellular stress responses through changes in fatty acid availability and downstream lipid mediators.
HSL CRISPR Activation Plasmid (h) provides a targeted, non-destructive approach to upregulating endogenous LIPE expression without altering the underlying DNA sequence.
HSL CRISPR Activation Plasmid (h) is a three-plasmid synergistic activation mediator (SAM) system engineered for highly efficient, site-specific transcriptional upregulation of the LIPE locus in human cell lines. The system is built around a catalytically inactive Cas9 (dCas9) carrying two inactivating mutations (D10A and N863A) that eliminate nuclease activity while preserving DNA binding. This dCas9 is fused to VP64, a potent transcriptional activator, and is co-expressed with a blasticidin resistance gene for selection. The second plasmid encodes the MS2-p65-HSF1 fusion protein, a secondary activator complex that works in concert with dCas9-VP64, alongside a hygromycin resistance gene. The third plasmid encodes a target-specific 20 nt sgRNA fused to two MS2 RNA aptamers that recruit the MS2-p65-HSF1 complex to the activation site, accompanied by a puromycin resistance gene. The three plasmids are delivered at a 1:1:1 mass ratio for balanced expression of all system components.
Once assembled at the target locus, the SAM complex binds within approximately 200 bp upstream of the LIPE transcriptional start site, where VP64, p65, and HSF1 act in concert to recruit transcriptional machinery and drive upregulation of endogenous HSL expression. Unlike nuclease-active Cas9, dCas9 does not introduce double-strand breaks or modify the genomic sequence, preserving the native LIPE locus and enabling the study of HSL-dependent transcriptional responses at the endogenous locus, making it a valuable tool for functional studies, target gene identification, and the modeling of HSL pathway restoration in tumor cells with silenced or reduced LIPE expression.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.